# Weight Gain Prevention in Adolescents and Young Adults

> **NCT06905626** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Minnesota** · enrollment: 140 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Qsymia 7.5 miligrams (mg)-46 mg Extended Release Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06905626
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2030-03-31
- **Final completion:** 2031-03-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06905626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06905626, "Weight Gain Prevention in Adolescents and Young Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06905626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*